Sarepta Therapeutics (SRPT) Halted on LUDP
- Wall St. stock futures fall after Italy referendum
- Oil tops $55 for first time in 16 months as OPEC deal fuels buying
- Consolidated Communications (CNSL) to Acquire FairPoint Communications (FRP) in $1.5B Deal
- Burberry rejects multiple takeover offers from Coach: Financial Times
- Trump picks ex-rival Carson to head housing department
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Sarepta Therapeutics (NASDAQ: SRPT) Halted on LUDP
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aetna (AET) covers Sarepta Therapeutics (SRPT) Exondys 51, with restrictions - Bloomberg
- Stocks with Implied Volatility Movement
- Sarepta Therapeutics (SRPT) Exondys 51 'Medically Necessary' at Aetna When Certain Criteria are Met
Create E-mail Alert Related CategoriesMomentum Movers, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!